http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2678135-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0424d3fb2b11ca4cca198f91e6cdc75d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4742 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-32 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2015-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc5ad869972bcab1dde349c8daeb2d22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_193540b4e800a9a015e5f847261535ab |
| publicationDate | 2019-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2678135-C1 |
| titleOfInvention | Composition and method for detecting malignant neoplastic disease |
| abstract | FIELD: biotechnology. n SUBSTANCE: invention relates to the field of biotechnology, specifically to a composition for the specific binding of a heterotypic complex of keratin 7 to keratin 19, that can be used in medicine. Composition contains at least two targeted agents, the first targeted agent recognizing keratin 7 peptide and/or its fragment (-s) and one second targeted agent recognizes keratin 19 peptide and/or its fragment(s), where the first and second targeted agents are able to bind specifically and simultaneously with heterotypic keratin 7 complex with keratin 19 and/or its fragment (-s). n EFFECT: invention allows to diagnose and/or predict the effectiveness of treatment, evaluate the results of treatment, evaluate the recurrence of a malignant neoplastic disease, such as, for example, lung cancer, bladder cancer, esophageal cancer and ovarian cancer in a subject. n 33 cl, 5 dwg, 13 ex, 8 tbl |
| priorityDate | 2014-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 182.